Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

108.83 +2.74 (+2.58%)

Streaming Delayed Price Updated: 1:27 PM EST, Jan 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

52 53 Next >

Abbott Laboratories (NYSE:ABT) Shows Strong Technical Breakout Potential ↗

May 01, 2025

Abbott Laboratories (NYSE:ABT) Shows Strong Technical Breakout Potential

Via Chartmill

A Look Into Abbott Laboratories Inc's Price Over Earnings ↗

April 28, 2025

Via Benzinga

3 Dividend Stocks to Buy and Hold for the Next Decade ↗

April 28, 2025

Via The Motley Fool

If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy

April 25, 2025

AbbVie is well-positioned for industry-leading growth, as Skyrizi and Rinvoq sales outperform, driving system-wide growth alongside a diversified portfolio.

Via MarketBeat

What To Expect From Penumbra’s (PEN) Q1 Earnings

April 22, 2025

Medical device company Penumbra (NYSE:PEN) will be reporting results tomorrow after the bell. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow

April 22, 2025

Medical device company ResMed (NYSE:RMD) will be announcing earnings results tomorrow after market close. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence

What To Expect From Boston Scientific’s (BSX) Q1 Earnings

April 22, 2025

Medical device company Boston Scientific (NYSE:BSX) will be reporting results tomorrow before market open. Here’s what to look for.

Via StockStory

Topics Economy

Earnings To Watch: Intuitive Surgical (ISRG) Reports Q1 Results Tomorrow

April 21, 2025

Medical technology company Intuitive Surgical (NASDAQ:ISRG) will be reporting results tomorrow after market close. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

10 Health Care Stocks Whale Activity In Today's Session ↗

April 18, 2025

Via Benzinga

Dividend Stock Analysis: Abbott Laboratories ↗

April 18, 2025

The company is focused on nutritionals, diagnostics, generic drugs, and medical devices.

Via Talk Markets

Topics Stocks / Equities

These Analysts Boost Their Forecasts On Abbott Laboratories After Better-Than-Expected Earnings ↗

April 17, 2025

Via Benzinga

Demystifying Abbott Laboratories: Insights From 11 Analyst Reviews ↗

April 17, 2025

Via Benzinga

5 Dividend Aristocrats® So Good You'll Never Want to Sell ↗

April 17, 2025

Turn $180 into $7M? These 5 Dividend Aristocrats show how it's possible.

Via The Motley Fool

Tariff-Resistant Abbott Laboratories on Track for New Highs

April 17, 2025

Abbott Laboratories stock price is on track to hit a new high in 2025 and could do it before the end of the first half. Dividends and buybacks help.

Via MarketBeat

Topics World Trade

US Stocks Likely To Open Higher Ahead Of Festive Weekend: 'Current Equity Levels Offer An Attractive Entry Opportunity' ↗

April 17, 2025

U.S. stock futures rose on Thursday ahead of the long weekend, with Good Friday falling on April 18 and Easter Sunday on April 20.

Via Benzinga

Nasdaq Dips 3% Amid Plunge In Nvidia, AMD: Greed Index Remains In 'Extreme Fear' Zone ↗

April 17, 2025

Via Benzinga

Healthcare Sector Update: MEDtech And Diagnostics ↗

April 16, 2025

Amidst the tariff chaos, we may get clues from one of the most defensive sectors of the market-healthcare stocks.

Via Talk Markets

Topics ETFs Stocks / Equities World Trade

Stay informed with the top movers within the S&P500 index on Wednesday. ↗

April 16, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.

Via Chartmill

Stocks Sink As Powell Dismisses 'Fed Put' Safety Net, Gold Extends Massive Lead Over Nasdaq ↗

April 16, 2025

Powell says tariffs could lead to higher inflation and slower growth, but Fed won't intervene in market losses. Stocks tumble, gold prices rise.

Via Benzinga

Topics Economy World Trade

Discover which S&P500 stocks are making waves on Wednesday. ↗

April 16, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Nvidia Drags Wall Street Down, Gold Defies Gravity Ahead Of Powell Remarks: What's Driving Markets Wednesday? ↗

April 16, 2025

U.S. major indices traded lower at midday Wednesday, pressured by sharp declines in tech and semiconductor stocks after Washington tightened chip export restrictions to China.

Via Benzinga

Abbott Laboratories (ABT) Shares Skyrocket, What You Need To Know

April 16, 2025

Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) jumped 5.4% in the morning session after the company reported decent first-quarter 2025 results with revenue in line,...

Via StockStory

Nasdaq Down Over 2%; Abbott Laboratories Posts Upbeat Earnings ↗

April 16, 2025

Via Benzinga

Abbott Stock Rises On Strong Q1 Earnings: Retail’s In Wait-And-Watch Mode ↗

April 16, 2025

Abbott reaffirmed its full-year 2025 financial guidance and expects full-year 2025 adjusted diluted earnings per share of $5.05 to $5.25.

Via Stocktwits

Topics Government

Abbott Labs Clocks Q1 Profit Beat, CEO Says Diversification And Execution Enable Navigation During Uncertainty ↗

April 16, 2025

Abbott reaffirmed its 2025 EPS guidance supported by strong Diabetes and Nutrition growth.

Via Benzinga

Abbott Laboratories Dips As Sales Come In Light Despite Profit Beat ↗

April 16, 2025

Abbott stock slipped early Wednesday after the health giant reported light first-quarter sales, though profit beat views.

Via Investor's Business Daily

Abbott Laboratories (NYSE:ABT) Posts Q1 Sales In Line With Estimates

April 16, 2025

Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 4% year on year to $10.36 billion. Its non-GAAP profit of $1.09...

Via StockStory

Abbott Laboratories Reports Strong First Quarter Results, Maintains Positive Outlook ↗

April 16, 2025

Abbott Laboratories reported a strong start to 2025 with significant growth in sales and EPS, exceeding market expectations.

Via Talk Markets

Topics Stocks / Equities

US Stock Likely To Open Lower As US-China Tariff War Continues: 'Valuations Are Now Looking More Compelling,' Says Expert ↗

April 16, 2025

U.S. stock futures declined on Wednesday following a muted day of trading on Tuesday. Futures of indices were lower in premarket.

Via Benzinga

Earnings Scheduled For April 16, 2025 ↗

April 16, 2025

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

52 53 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.